This index tracks treatment directions, repurposed drug trials, devices, and other clinical interventions. It is organized around what readers are most likely to look for by name, while individual thread pages keep the evidence level and uncertainty explicit.
Active Treatment Threads
- Daratumumab & Plasma-Cell Targeting - anti-CD38 plasma-cell depletion, ResetME, and antibody-depletion strategies.
- Low-Dose Naltrexone (LDN) - LDN, dextro-naltrexone, TRPM3 ion-channel findings, and neuroimmune rationale.
- Rapamycin & mTOR Inhibition - low-dose sirolimus, mTOR signaling, and autophagy-targeting strategies.
- Hyperbaric Oxygen Therapy (HBOT) - HBOT studies, tissue oxygenation, perfusion, and neurological outcome signals.
- Immunoadsorption & Apheresis - extracorporeal blood-filtration approaches targeting autoantibodies, microclots, or perfusion.
- Antivirals & Monoclonal Antibodies - antiviral drugs and pathogen-targeting monoclonal antibody strategies.
- Vagus & Tragus Nerve Stimulation - transcutaneous, auricular, or related nerve-stimulation interventions.
- Na-K-ATPase & Muscle Ion Transport - early pump-targeting hypotheses around sarcolemmal depolarisation, muscle weakness, fasciculations, and severe ME/CFS.
- Emerging Pharmacotherapy - smaller repurposed-drug and supplement leads that do not yet warrant their own thread.
How To Read These Threads
Treatment threads are not recommendations. They are evidence trackers: each page should distinguish trial design, early signals, negative or inconclusive findings, and source limitations.
Not Medical Advice
These pages summarize research and are not treatment guidance. Always consult a qualified clinician and read original sources before making health decisions.